← Open Payments lookup

MELANIE COKER: Open Payments

NPI 1376609990 · JACKSON, MS. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$1,091 in 47 payments from 11 companies in 2025. Trend: 2023 $856 · 2024 $1,113 · 2025 $1,091

Food & beverage: $1,091
CompanyPaymentsAmount
Merck Sharp & Dohme LLC9$230
GlaxoSmithKline, LLC.10$186
Eisai Inc.4$183
Genmab U.S., Inc.5$124
ABBVIE INC.5$93
AstraZeneca Pharmaceuticals LP4$68
Caris MPI, Inc.3$55
VERTEX PHARMACEUTICALS INCORPORATED3$54
Astellas Pharma US Inc2$42
Myriad Genetic Laboratories, Inc.1$33

Products named: JEMPERLI, Lenvima, LYNPARZA, KEYTRUDA, ELAHERE, Tivdak, MI CANCER SEEK, JOURNAVX.

Industry payments across MS — which companies pay providers there.